Skip to main content
Premium Trial:

Request an Annual Quote

Ipsogen, Cleveland Clinic Go Hunting for Breast Cancer Biomarkers

NEW YORK, Oct. 27 (GenomeWeb News) - Ipsogen will collaborate with The Cleveland Clinic to identify molecular markers in early-stage breast cancer, the company said today.

 

Ipsogen, of Marseille, France, will use its gene expression-profiling and bioinformatics tools to find markers that predict patient risk for breast cancer recurrence. Researchers at The Cleveland Clinic will contribute its expertise in breast cancer management.

 

Terms of the collaboration were not disclosed.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.